These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Disparate effects of prazosin and propranolol on lipid metabolism in a rat model. Dall'Aglio E; Chang H; Reaven G Metabolism; 1983 May; 32(5):510-3. PubMed ID: 6843362 [TBL] [Abstract][Full Text] [Related]
48. The influence of prazosin and propranolol on serum lipids and atherosclerosis in standard fed pigs. Helgeland A; Eriksen K; Foss PO; Nafstad I; Solberg LA; Tollersrud S Acta Pharmacol Toxicol (Copenh); 1984 Apr; 54(4):270-2. PubMed ID: 6730983 [TBL] [Abstract][Full Text] [Related]
49. [Influence of indomethacin and clidanac on the blood pressure lowering effect of beta-blockers]. Imai H; Niwa M; Nozaki M; Tsurumi K; Fujimura H Nihon Yakurigaku Zasshi; 1983 Jan; 81(1):13-20. PubMed ID: 6133820 [TBL] [Abstract][Full Text] [Related]
50. Effects of indomethacin and etodolac on coronary blood flow and other cardiovascular variables in propranolol-treated dogs. Beaulieu G Arch Int Pharmacodyn Ther; 1985 Apr; 274(2):283-90. PubMed ID: 3161477 [TBL] [Abstract][Full Text] [Related]
51. The effect of age on the sensitivity of the alpha 1-adrenoceptor to phenylephrine and prazosin. Klein C; Gerber JG; Payne NA; Nies AS Clin Pharmacol Ther; 1990 Apr; 47(4):535-9. PubMed ID: 2158407 [TBL] [Abstract][Full Text] [Related]
52. Alpha adrenergic blockade by prazosin in therapy of essential hypertension. Ram CV; Anderson RJ; Hart GR; Crumpler CP Clin Pharmacol Ther; 1981 Jun; 29(6):719-22. PubMed ID: 6112091 [TBL] [Abstract][Full Text] [Related]
53. Pharmacokinetic and pharmacodynamic studies with two alpha-adrenoceptor antagonists, doxazosin and prazosin in the rabbit. Hamilton CA; Reid JL; Vincent J Br J Pharmacol; 1985 Sep; 86(1):79-87. PubMed ID: 2864970 [TBL] [Abstract][Full Text] [Related]
54. Metabolic effects of prazosin. Barbieri C; Caldara R; Ferrari C; Dal Bo GA; Paracchi A; Romussi M; Curtarelli G Clin Pharmacol Ther; 1980 Mar; 27(3):313-6. PubMed ID: 6102000 [TBL] [Abstract][Full Text] [Related]
55. Alpha-receptor function changes after the first dose of prazosin. von Bahr C; Lindström B; Seideman P Clin Pharmacol Ther; 1982 Jul; 32(1):41-7. PubMed ID: 6282526 [TBL] [Abstract][Full Text] [Related]
56. Tissue distribution and hypotensive effect of prazosin in the conscious rat. Dynon MK; Jarrott B; Louis WJ J Cardiovasc Pharmacol; 1983; 5(2):235-9. PubMed ID: 6188896 [TBL] [Abstract][Full Text] [Related]
57. [Clinical pharmacology of prazosin in arterial hypertension with chronic renal insufficiency]. Chaignon M; Le Roux E; Aubert P; Lucsko M; Flouvat B; Guédon J Arch Mal Coeur Vaiss; 1981 Jun; 74 Spec No():71-7. PubMed ID: 6794530 [TBL] [Abstract][Full Text] [Related]
58. Prazosin update. A review of its pharmacological properties and therapeutic use in hypertension and congestive heart failure. Stanaszek WF; Kellerman D; Brogden RN; Romankiewicz JA Drugs; 1983 Apr; 25(4):339-84. PubMed ID: 6303744 [TBL] [Abstract][Full Text] [Related]
59. [Changes in renal arterial flow during the treatment of essential arterial hypertension; prazosin in comparison with propranolol]. O'Connor DT; Preston RA; Sasso EH Cardiology; 1980; 66 Suppl 2():69-73. PubMed ID: 7285032 [No Abstract] [Full Text] [Related]